Overview
- 43 inspections across 43 sites are on record.
- 53 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-10-11.
At a glance
Inspections
43
Sites
43
Observations
53
Career since
Oct 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Von Mehren M.D., Margaret | 11 Oct 2019 | Human Drugs | |
| Elizabeth Plimack, MD, MS | 26 Sep 2019 | Human Drugs | View 483 → |
| Evan Alley, M.D., Ph.D. | 5 Sep 2019 | Human Drugs | View 483 → |
| Anthony J. Olszanski, M.D., RPh | 25 Jul 2019 | Human Drugs | View 483 → |
| Luitpold Pharmaceuticals, Inc. | 25 Jul 2019 | Human Drugs |
Sites inspected
Von Mehren M.D., MargaretPhiladelphia, United States1 insp.
Elizabeth Plimack, MD, MSPhiladelphia, United States1 insp.
Evan Alley, M.D., Ph.D.Philadelphia, United States1 insp.
Anthony J. Olszanski, M.D., RPhPhiladelphia, United States1 insp.
Luitpold Pharmaceuticals, Inc.Norristown, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Anastasia I Onuorah11 shared
Stephanie C Mangigian4 shared
Dhaval H Patel2 shared
Michael Serrano2 shared
Nina Yang2 shared
Nancy M Espinal2 shared
Gabrielle J Swain1 shared
Christopher Bastedo1 shared
Kelly N Kerr1 shared
Joseph L Despins1 shared
Full investigator report
Get the verbatim findings behind Anastasia I Offordile's 53 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site